No Data
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Analyst Ratings
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Cuts Target Price to $28
Express News | STAAR Surgical Co : Canaccord Genuity Cuts Target Price to $28 From $31
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Cuts Target Price to $23